User profiles for G. Dervenoulas
George DervenoulasKing's College London Verified email at kcl.ac.uk Cited by 1090 |
[HTML][HTML] Magnetic resonance imaging in Alzheimer's disease and mild cognitive impairment
Research utilizing magnetic resonance imaging (MRI) has been crucial to the understanding
of the neuropathological mechanisms behind and clinical identification of Alzheimer’s …
of the neuropathological mechanisms behind and clinical identification of Alzheimer’s …
Advances in MRI methodology
T Yousaf, G Dervenoulas, M Politis - International review of neurobiology, 2018 - Elsevier
… G z , G y and G x signify the magnetic field gradients in the slice-select, phase-encoding
and frequency-encoding directions, respectively. Apparent diffusion coefficient (ADC) signifies …
and frequency-encoding directions, respectively. Apparent diffusion coefficient (ADC) signifies …
Applications of amyloid, tau, and neuroinflammation PET imaging to Alzheimer's disease and mild cognitive impairment
Alzheimer's disease (AD) is a devastating and progressive neurodegenerative disease for
which there is no cure. Mild cognitive impairment (MCI) is considered a prodromal stage of the …
which there is no cure. Mild cognitive impairment (MCI) is considered a prodromal stage of the …
Imidazoline 2 binding sites reflecting astroglia pathology in Parkinson's disease: an in vivo11C-BU99008 PET study
H Wilson, G Dervenoulas, G Pagano, RJ Tyacke… - Brain, 2019 - academic.oup.com
Astroglia are multifunctional cells that regulate neuroinflammation and maintain homeostasis
within the brain. Astroglial α-synuclein-positive cytoplasmic accumulations have been …
within the brain. Astroglial α-synuclein-positive cytoplasmic accumulations have been …
Serotonergic pathology and disease burden in the premotor and motor phase of A53T α-synuclein parkinsonism: a cross-sectional study
H Wilson, G Dervenoulas, G Pagano, C Koros… - The Lancet …, 2019 - thelancet.com
Background Because of the highly penetrant gene mutation and clinical features consistent
with idiopathic Parkinson's disease, carriers of the autosomal dominant Ala53Thr (A53T; …
with idiopathic Parkinson's disease, carriers of the autosomal dominant Ala53Thr (A53T; …
[HTML][HTML] Neuroimaging in Lewy body dementia
T Yousaf, G Dervenoulas, PE Valkimadi, M Politis - Journal of neurology, 2019 - Springer
Lewy body dementia (DLB) is a common form of cognitive impairment, accounting for 30%
of dementia cases in ages over 65 years. Early diagnosis of DLB has been challenging; …
of dementia cases in ages over 65 years. Early diagnosis of DLB has been challenging; …
Aquaporin-4 polymorphisms predict amyloid burden and clinical outcome in the Alzheimer's disease spectrum
Clearance of amyloid-β (Aβ) from the brain is hypothesized to be mediated by the glymphatic
system through aquaporin-4 (AQP4) water channels. Genetic variation of AQP4 may impact …
system through aquaporin-4 (AQP4) water channels. Genetic variation of AQP4 may impact …
Double seronegative myasthenia gravis with low density lipoprotein-4 (LRP4) antibodies presenting with isolated ocular symptoms
… Author links open overlay panel Georgios Tsivgoulis a b , Georgios Dervenoulas a ,
Panagiotis Kokotis a c , Christina Zompola a , John S. … Dr Dervenoulas reports no disclosures. …
Panagiotis Kokotis a c , Christina Zompola a , John S. … Dr Dervenoulas reports no disclosures. …
[HTML][HTML] [18F]Florbetapir PET/MR imaging to assess demyelination in multiple sclerosis
A Carotenuto, B Giordano, G Dervenoulas… - European Journal of …, 2020 - Springer
… George Dervenoulas … CBF is measured in ml/100 g/min. … Klunk WE, Engler H, Nordberg
A, Wang Y, Blomqvist G, Holt DP, et al. Imaging brain amyloid in Alzheimer's disease with …
A, Wang Y, Blomqvist G, Holt DP, et al. Imaging brain amyloid in Alzheimer's disease with …
Structural magnetic resonance imaging in Huntington's disease
H Wilson, G Dervenoulas, M Politis - International review of neurobiology, 2018 - Elsevier
Huntington's disease (HD) is an autosomal dominant neurodegenerative disorder, caused
by expansion of the CAG repeat in the huntingtin gene. HD is characterized clinically by …
by expansion of the CAG repeat in the huntingtin gene. HD is characterized clinically by …